Filing Signals

Source: SEC EDGAR Compiled 2026-08-23 04:41 UTC Unattended

← All events

ProPhase Labs, Inc.

CIK 868278 PRPH·Pharmaceutical Preparations · All EDGAR filings ↗

Late filing elevated Filing comparison

ProPhase Labs, Inc. told the SEC it could not file its quarterly report on time

Does not expect a significant change in results. other reports also outstanding

(the “Company”) is unable, without unreasonable effort or expense, to timely file its Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2026. The delay in filing is primarily due to the additional time required to complete the Company’s review procedures performed by the Company’s independent registered public accounting firm. The Company is working diligently with its auditors to finalize the financial statements and related disclosures.
Evidence
Anticipates significant change
False
Other periodic reports filed
False
Severity
high
Source
Form 12b-25 (notification of late filing)
Stated reason
(the “Company”) is unable, without unreasonable effort or expense, to timely file its Quarterly Report on Form 10-Q for the Quarter Ended June 30, 2026. The delay in filing is primarily due to the additional time required to complete the Company’s review procedures performed by the Company’s independent registered public accounting firm. The Company is working diligently with its auditors to finalize the financial statements and related disclosures.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.